References and Notes
Reviews:
1a
Tejedor D.
Garcia-Tellado F.
Org. Prep. Proced. Int.
2004,
36:
33
1b
Zografos AL.
Georgiadis D.
Synthesis
2006,
3157
2a
Gill M.
Steglich W.
Prog. Chem. Org. Nat. Prod.
1987,
51:
1
2b
Rao YS.
Chem. Rev.
1976,
76:
625
For reviews on the Dieckmann condensation, see:
3a
Davis BR.
Garrett PJ. In Comprehensive Organic Synthesis
Vol. 2:
Trost BM.
Fleming I.
Pergamon;
Oxford:
1991.
p.806-829
3b
Schaefer JP.
Bloomfield JJ.
Org. React.
1967,
15:
1
For recent syntheses of tetronic acids via Dieckmann condensation, see:
4a Pulvinones: Bernier D.
Moser F.
Brückner R.
Synthesis
2007,
2240
4b See also: Bernier D.
Brückner R.
Synthesis
2007,
2249
4c Retipolide E, ornatipolide: Ingerl A.
Justus K.
Hellwig V.
Steglich W.
Tetrahedron
2007,
63:
6548
4d Abyssomicin C, atrop-abyssomicin C, and abyssomicin D: Nicolaou KC.
Harrison ST.
J. Am. Chem. Soc.
2007,
129:
429
4e (+)-Tetronolide: Boeckman RK.
Shao P.
Wrobleski ST.
Boehmler DJ.
Heintzelman GR.
Barbosa AJ.
J. Am. Chem. Soc.
2006,
128:
10572
4f Quartromicins: Trullinger TK.
Qi J.
Roush WR.
J. Org. Chem.
2006,
71:
6915
4g Secretase inhibitors: Larbig G.
Schmidt B.
J. Comb. Chem.
2006,
8:
480
5
Bretschneider T.
Benet-Buchholtz J.
Fischer R.
Nauen R.
Chimia
2003,
57:
697 ; and references therein
6
Weber V.
Rubat C.
Duroux E.
Lartigue C.
Madesclaire M.
Coudert P.
Bioorg. Med. Chem.
2005,
13:
4552
For previous studies on the synthesis of pulvinic derivatives in our laboratory, see:
7a
Desage-El Murr M.
Nowaczyk S.
Le Gall T.
Mioskowski C.
Amekraz B.
Moulin C.
Angew. Chem. Int. Ed.
2003,
42:
1289
7b
Heurtaux B.
Lion C.
Le Gall T.
Mioskowski C.
J. Org. Chem.
2005,
70:
1474
7c
Desage-El Murr M.
Nowaczyk S.
Le Gall T.
Mioskowski C.
Eur. J. Org. Chem.
2006,
1489
7d
Willis C.
Bodio E.
Bourdreux Y.
Billaud C.
Le Gall T.
Mioskowski C.
Tetrahedron Lett.
2007,
48:
6421
8
Lloyd-Jones GC.
Angew. Chem. Int. Ed.
2002,
41:
953 ; and references therein
9
Campbell AC.
Maidment MS.
Pick JH.
Stevenson DFM.
J. Chem. Soc., Perkin Trans. 1
1985,
1567
10
Typical Experimental Procedures for Compound 3a
In DMF: To a solution of methyl 4-methoxyphenylacetate (0.318 mL, 2.0 mmol) and methyl glycolate (0.170 g, 2.2 mmol) in DMF (10 mL) was added a 1 M solution of KOt-Bu in THF (4.4 mL, 4.4 mmol). The solution was stirred under argon at r.t. for 2 h. The reaction mixture was then poured into cooled 1 N HCl (15 mL). The aqueous phase was extracted with EtOAc (3 × 10 mL), the combined organic layers were washed several times with brine, dried over Na2SO4. After filtration and concentration in vacuo, the residue was purified by column chromatography [silica gel, 200:1, then CH2Cl2-MeOH (95:5) containing 0.2% AcOH], to give compound 3a as a white solid (0.370 g, 90%).In THF: To a solution of methyl 4-methoxyphenylacetate (0.318 mL, 2.0 mmol) and methyl glycolate (0.170 g, 2.2 mmol) in anhyd, degassed THF (10 mL) was added a 1 M solution of KOt-Bu in THF (4.4 mL, 4.4 mmol). The suspension obtained was refluxed under argon for 16 h. After cooling to r.t., the reaction mixture was poured into 1 N HCl (15 mL). Treatment and purification as above afforded compound 3a as a white solid (0.350 g, 85%). Compound 3a: mp 228 °C (lit. 9: 228-229 °C). IR (neat): 2955, 1695, 1641, 1610, 1514, 1426, 1398, 1351, 1297, 1256, 1169, 1053, 1030, 1022, 960, 836, 736 cm-1. 1H NMR (400 MHz, acetone-d
6): δ = 3.81 (s, 3 H, OCH3), 4.76 (s, 2 H, CH2), 6.95 (d, J = 9.0 Hz, 2 H, CH), 7.94 (d, J = 9.0 Hz, 2 H, CH), 10.94 (br s, 1 H, OH). 13C NMR (100 MHz, acetone-d
6): δ = 55.5 (OCH3), 66.6 (C5), 100.3 (C3), 114.3 (C3
′), 123.8 (C1
′), 129.2 (C2
′), 159.4 (C4
′), 172.1, 173.5 (C2, C4). MS (ESI-TOF): m/z = 207 [M + H]+.